Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases

医学 肺癌 癌症 病理 肺 肿瘤科 内科学
作者
Richard S.P. Huang,Lukas Harries,Brennan Decker,Matthew Hiemenz,Karthikeyan Murugesan,James Creeden,Khaled A. Tolba,Laura P. Stabile,Shakti Ramkissoon,Timothy F. Burns,Jeffrey S. Ross
出处
期刊:Oncologist [AlphaMed Press]
卷期号:27 (10): 839-848 被引量:27
标识
DOI:10.1093/oncolo/oyac094
摘要

In patients with non-small cell lung cancer (NSCLC), 10%-40% will eventually develop brain metastases. We present the clinicopathologic, genomic, and biomarker landscape of a large cohort of NSCLC brain metastases (NSCLC-BM) samples.We retrospectively analyzed 3035 NSCLC-BM tested with comprehensive genomic profiling (CGP) during routine clinical care. In addition, we compared the NSCLC-BM to a separate cohort of 7277 primary NSCLC (pNSCLC) specimens. Finally, we present data on 67 paired patients with NSCLC-BM and pNSCLC.Comprehensive genomic profiling analysis of the 3035 NSCLC-BMs found that the most frequent genomic alterations (GAs) were in the TP53, KRAS, CDKN2A, STK11, CDKN2B, EGFR, NKX2-1, RB1, MYC, and KEAP1 genes. In the NSCLC-BM cohort, there were significantly higher rates of several targetable GAs compared with pNSCLC, including ALK fusions, KRAS G12C mutations, and MET amplifications; and decreased frequency of MET exon14 skipping mutations (all P < .05). In the subset of NSCLC-BM (n = 1063) where concurrent PD-L1 immunohistochemistry (IHC) was performed, 54.7% of the patients with NSCLC-BM were eligible for pembrolizumab based on PD-L1 IHC (TPS ≥ 1), and 56.9% were eligible for pembrolizumab based on TMB-High status. In addition, in a series 67 paired pNSCLC and NSCLC-BM samples, 85.1% (57/67) had at least one additional GA discovered in the NSCLC-BM sample when compared with the pNSCLC sample.Herein, we defined the clinicopathologic, genomic, and biomarker landscape of a large cohort of patients with NSCLC-BM which can help inform study design of future clinical studies for patients with NSCLC with BM. In certain clinical situations, metastatic NSCLC brain tissue or cerebral spinal fluid specimens may be needed to fully optimize personalized treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xmn完成签到,获得积分10
1秒前
1秒前
十年完成签到,获得积分10
2秒前
2秒前
落寞明雪发布了新的文献求助10
2秒前
zaphkiel发布了新的文献求助10
2秒前
披萨778完成签到,获得积分10
3秒前
3秒前
3秒前
sunnymoon发布了新的文献求助10
4秒前
犹豫的若发布了新的文献求助10
4秒前
小周发布了新的文献求助10
4秒前
丰富的德天完成签到 ,获得积分10
5秒前
5秒前
6秒前
6秒前
6秒前
6秒前
qingsan完成签到,获得积分10
6秒前
JJ发布了新的文献求助10
7秒前
41发布了新的文献求助10
7秒前
7秒前
FashionBoy的应助被科研通管家采纳,获得10
7秒前
null的应助被科研通管家采纳,获得10
7秒前
旧是完成签到 ,获得积分10
7秒前
玛卡巴卡的应助被科研通管家采纳,获得100
7秒前
李健的应助被科研通管家采纳,获得10
7秒前
时觉觉发布了新的文献求助10
7秒前
脑洞疼的应助被科研通管家采纳,获得10
8秒前
wanci的应助被科研通管家采纳,获得10
8秒前
yyyyy发布了新的文献求助10
8秒前
8秒前
8秒前
null的应助被科研通管家采纳,获得10
8秒前
8秒前
ppp完成签到,获得积分10
8秒前
Maestro_S的应助被科研通管家采纳,获得10
8秒前
9秒前
深情安青的应助被科研通管家采纳,获得10
9秒前
川了秋依关注了科研通微信公众号
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161554
求助须知:如何正确求助?哪些是违规求助? 9556174
关于积分的说明 21732775
捐赠科研通 7751537
什么是DOI,文献DOI怎么找? 3427556
关于科研通互助平台的介绍 2552588
邀请新用户注册赠送积分活动 2472023